Cochlear (ASX:COH) Stock Passes Above 200-Day Moving Average of $195.71

Cochlear Limited (ASX:COH) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $195.71 and traded as high as $211.75. Cochlear shares last traded at $211.68, with a volume of 228,557 shares traded.

The company has a debt-to-equity ratio of 25.02, a current ratio of 1.77 and a quick ratio of 1.14. The company has a 50-day simple moving average of A$216.95 and a two-hundred day simple moving average of A$195.71. The stock has a market capitalization of $12.23 billion and a price-to-earnings ratio of 44.15.

The firm also recently declared a Final dividend, which will be paid on Monday, October 14th. Stockholders of record on Monday, October 14th will be paid a $1.75 dividend. The ex-dividend date of this dividend is Thursday, September 19th. This represents a dividend yield of 0.8%. Cochlear’s payout ratio is 68.82%.

In other Cochlear news, insider Shah Abbas Hussain purchased 160 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The stock was bought at an average price of A$217.18 ($154.02) per share, with a total value of A$34,748.00 ($24,643.97). Also, insider Dig Howitt sold 8,227 shares of the stock in a transaction on Thursday, August 29th. The stock was sold at an average price of A$211.15 ($149.75), for a total value of A$1,737,131.05 ($1,232,007.84).

Cochlear Company Profile (ASX:COH)

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories.

Further Reading: What is an overbought condition?

Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with's FREE daily email newsletter.


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit